Showing results (321-330 of 1,945) with videos related to

Sort By:
Pageof 195
RMD Open|December 11, 2025
Circulating monocytes from systemic sclerosis patients with progressive interstitial lung disease preferentially express M2 phenotype markers: in vitro and ex vivo studyVanessa Smith, Stefano Soldano, Rosanna Campitiello, et al.
RMD Open|November 28, 2025
Identification of individuals at high risk of developing rheumatoid arthritis: a balanced random forest model in a cohort of 1544 first-degree relativesRomain Aymon, Céline Lamacchia, Benoit Thomas P Gilbert, et al.
RMD Open|June 22, 2025
Patients with psoriatic arthritis and comorbid metabolic syndrome show a difficult-to-treat phenotype: another mosaic tile in the definition of a still undefined subset of patientsDamiano Currado, Francesca Trunfio, Francesca Saracino, et al.
RMD Open|June 19, 2025
Bone health in juvenile idiopathic arthritis compared with controls based on a Norwegian observational studyAnette Lundestad, Lena Cetrelli, Oskar Welander Angenete, et al.
RMD Open|December 24, 2024
Rationale for phosphodiesterase-4 inhibition as a treatment strategy for interstitial lung diseases associated with rheumatic diseasesMartin Aringer, Oliver Distler, Anna-Maria Hoffmann-Vold, et al.
RMD Open|December 31, 2024
Induction of interleukin 21 receptor expression via enhanced intracellular metabolism in B cells and its relevance to the disease activity in systemic lupus erythematosusMasanobu Ueno, Shigeru Iwata, Kaoru Yamagata, et al.
RMD Open|January 25, 2025
Trends in work participation among patients with inflammatory rheumatic musculoskeletal diseases (iRMDs): Data from the German National Database (2010-2022)Carlo Veltri, Katinka Albrecht, Uta Kiltz, et al.
RMD Open|January 31, 2025
Trends to shorter diagnostic delay in spondyloarthritis patients during the last decades and association with clinical presentation: data from ASAS-COMOSPA studyRodolfo Perez-Alamino, Hernan Maldonado-Ficco, Anna Moltó, et al.
RMD Open|January 31, 2025
Porphyromonas gingivalis associates with the presence of anti-citrullinated protein antibodies, but not with the onset of arthritis: studies in an at-risk populationCharlotte De Vries, Alexandra Cîrciumaru, Linda Mathsson-Alm, et al.
RMD Open|January 31, 2025
Long-term safety and sustained efficacy of bimekizumab in patients with ankylosing spondylitis (radiographic axial spondyloarthritis): 5-year results from BE AGILE (phase 2b) and its open-label extensionAtul Deodhar, Victoria Navarro-Compán, Denis Poddubnyy, et al.
Pageof 195